OncoResponse, Inc — Form D

OncoResponse, Inc of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-31. The offering totals $60.0M, of which $40.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
Roberto DePontiDirectorNone, N4
Steven GillisDirectorSouth San Francisco, CA
Patrick Joseph HojloDirectorDoha, S3
Wende HuttonDirectorMenlo Park, CA
TED KOUTOUZISDirectorSANTA CLARA, CA
John McKearnDirectorSeattle, WA
Clifford StocksDirectorHouston, TX
Daguang Joseph WangDirectorCambridge, MA
Bob Joseph LechleiderExecutive OfficerSeattle, WA
Kamal Joseph PuriExecutive OfficerSeattle, WA
Clifford StocksExecutive OfficerHouston, TX
Steve GillisDirectorNew York, NY
Andrew PerlmanDirectorAtlanta, GA
Geeta VemuriDirectorWaltham, MA
Sean A McCarthyDirectorHOUSTON, TX
Roberto D De PontiDirectorHOUSTON, TX
Alice J BexonExecutive OfficerHOUSTON, TX
Steven D GillisDirectorHOUSTON, TX
Clifford J StocksDirectorHOUSTON, TX
Clifford J StocksExecutive OfficerHOUSTON, TX
Kamal D PuriExecutive OfficerHOUSTON, TX
Carol D GallagherDirectorHOUSTON, TX
John A McKearnDirectorHOUSTON, TX
Chris D RussellExecutive OfficerHOUSTON, TX
Wende D HuttonDirectorHOUSTON, TX

Other filings by this issuer (6)

FiledFormOfferingSold
2025-05-06D$6.0M
2023-05-12D$40.0M$13.9M
2018-09-06D$40.0M$19.0M
2017-03-23D/A$34.0M$29.5M
2016-05-26D/A$28.2M$19.5M
2015-10-15D$28.2M$16.5M

More